Arteris, INC Form 4 insider transactions

Nicholas B. Hawkins, VP and CFO of Arteris, Inc., sold shares of common stock on July 2nd and 3rd, 2024, to cover tax liabilities related to the release of restricted stock units.

Charles Janac, President and CEO of Arteris, Inc., executed multiple sales of common stock between July 1st and July 3rd, 2024, under a pre-arranged 10b5-1 trading plan.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on July 1st and 2nd, 2024, to cover tax liabilities arising from the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports exercising stock options and selling shares to cover tax obligations, according to a Form 4 filing.

Director Antonio J. Viana of Arteris, Inc. sold 2,836 shares of common stock at an average price of $8.1026 on June 10, 2024, under a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza transfers shares to a revocable trust, affecting both direct and indirect ownership of Arteris, Inc. stock.

Director Antonio J. Viana reports share transfers to the Viana Family Trust and sales under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. CEO Charles Janac sold shares of common stock on June 4, 2024, to cover tax liabilities related to the release of restricted stock units.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on June 4th and 5th, 2024, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold 611 shares of common stock on June 4, 2024, to satisfy tax liabilities related to the release of restricted stock units.

Director Isabelle F. Geday reports acquiring 19,287 shares of Arteris, Inc. common stock through restricted stock units.

Director Antonio J. Viana reports acquiring 19,287 shares of Arteris, Inc. common stock through restricted stock units.

Director Claudia F. Munce reports acquisition of 19,287 restricted stock units (RSUs) of Arteris, Inc.

Director Raman Chitkara reports acquiring 19,287 shares of Arteris, Inc. common stock through restricted stock units.

Director Saiyed Atiq Raza reports the acquisition of 19,287 restricted stock units (RSUs) of Arteris, Inc.

Director Wayne C. Cantwell reports acquisition of 32,145 restricted stock units (RSUs) of Arteris, Inc.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports multiple transactions involving the sale of common stock and the exercise of stock options, pursuant to a pre-arranged 10b5-1 trading plan.

Nicholas B. Hawkins, CFO of Arteris, Inc., sold 10,000 shares of common stock at an average price of $8.0067 on May 13, 2024, under a pre-arranged 10b5-1 trading plan.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports the exercise of options and sale of common stock under a pre-arranged 10b5-1 trading plan.

Nicholas B. Hawkins, VP and CFO of Arteris, Inc., sold 10,000 shares of common stock at an average price of $7.2161 on April 11, 2024, according to a Form 4 filing.

Director Antonio J. Viana reports acquiring 2,781 shares of Arteris, Inc. common stock in lieu of cash retainer fees.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on April 2nd and 4th, 2024, to cover tax liabilities related to the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold shares of common stock on April 2nd and 3rd, 2024, to cover tax liabilities related to the release of restricted stock units.

Arteris, Inc. CEO Charles Janac sold shares of common stock on April 2, 2024, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on April 2nd and 3rd, 2024, to cover tax liabilities arising from the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., reports exercising stock options and selling shares under a pre-arranged 10b5-1 trading plan.

Nicholas Hawkins, CFO of Arteris, Inc., sold 10,000 shares of common stock at an average price of $6.9782 on March 11, 2024, under a pre-arranged 10b5-1 trading plan.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on March 4th and 5th, 2024, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold a portion of his common stock to cover tax liabilities arising from the release of restricted stock units.

Arteris, Inc. CEO Charles Janac sold shares of common stock on March 4, 2024, to cover tax liabilities and as part of a pre-arranged trading plan.